|
Match
|
Document |
Document Title |
|
|
8101095 |
Antiferroelectric orthoconic liquid crystalline material with long pitch and the method of its preparation
The racemic and chiral compounds expressed by common formula 1 and formula 2: wherein the lateral substituents X1, X2, X3, X4, X5, X6, X7 and X8 in the benzene rings represent independently...
|
|
|
8043789 |
Photosensitive compound and photoresist composition including the same
A photosensitive compound whose size is smaller than conventional polymer for photoresist, and which has well-defined (uniform) structure, and a photoresist composition including the same are...
|
|
|
8003698 |
Site-specific inhibitors of histone methyltransferase (HMTASE) and process of preparation thereof
The present invention relates to compounds of structural formula I as site-specific inhibitors of histone methyltransferase, where R1 and R1 is —OCH3 or —OH, R2 and R2 is —OH or —OAc; a process...
|
|
|
7968155 |
Optically anisotropic material, liquid crystal display device and triphenylene compound
An optically anisotropic material comprising at least one discotic compound having a cyclopropylcarbonyl group. The material is excellent in both the wavelength dispersion property and the...
|
|
|
7910019 |
Mesogen containing compounds
Compounds including at least one mesogenic substructure and at least one long flexible segment and methods of synthesizing the same are disclosed. Formulations which include various embodiments of...
|
|
|
7910020 |
Liquid crystal compositions comprising mesogen containing compounds
Liquid crystal compositions comprising compounds including at least one mesogenic substructure and at least one long flexible segment and a compound selected from a photochromic compound, a...
|
|
|
7893270 |
Process for the production of cyclic diketones
The present invention relates to a process for the preparation of compounds of formula (I), wherein the substituents are as defined in claim 1, by reacting a compound of formula (II), with a...
|
|
|
7875741 |
Site-specific inhibitors of histone methyltransferase [HMTase] and process of preparation thereof
The present invention relates to compounds of structural formula I as site-specific inhibitors of histone methyltransferase, where R1 and R1 is —OCH3 or —OH, R2 and R2 is —OH or —OAc; a process...
|
|
|
7816385 |
Dimeric dicarboxylic acid derivatives, their preparation and use
A novel class of dicarboxylic acid derivatives, the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing...
|
|
|
7745099 |
Photosensitive compound and photoresist composition including the same
A photosensitive compound as a molecular resist whose size is smaller than conventional polymer for photoresist, and which can form a nano assembly, and a photoresist composition including the same...
|
|
|
7737176 |
Substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them
The invention relates to compounds of the formula I: and to the pharmaceutically acceptable salts thereof, to processes for the preparation of them and to pharmaceutical compositions comprising...
|
|
|
7674922 |
Process for production of delta-9-tetrahydrocannabinol
The present invention relates to a process for preparation of a delta-9-tetrahydrocannabinol compound or derivative thereof involving treating a first intermediate compound with an...
|
|
|
7618690 |
Polymerizable liquid crystal compound, liquid crystal composition, optical anisotropic material and optical element
A liquid crystal compound represented by the formula CH2═CR1—COO-(L)k-E1-E2-E3-E4-R2 wherein R1: a hydrogen atom or a methyl group; R2: a C1-8 alkyl group; k: 0 or 1; L: —(CH2)pO— or —(CH2)q...
|
|
|
7442418 |
Polymerizable liquid crystal compound, liquid crystal composition, optical anisotropic material and optical element
The present compound represented by formula(I) CH2═CR1—COO—(L)k-E1-E2-E3-(E4)m-(E5)n-R2 (1) provided that the symbols in the formula have the following meanings: R1: a hydrogen atom or a methy...
|
|
|
7427685 |
Therapeutic substituted cyclopentanes
Therapeutic compounds according to one of the structures below are disclosed herein.
|
|
|
7425603 |
Polymers, polymer compositions, and method of preparation
A polymer comprising structural units derived from a polycyclic dihydroxy compound of Formula (I) wherein R1, R2 and R3 are independently at each occurrence selected from the group consisting of a...
|
|
|
7232821 |
(2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives
Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, R1, R2, Rx, R8, R9 and n are as defined in the specification, a process for the preparation of such...
|
|
|
7037914 |
Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
A peroxisome proliferator activated receptor regulator containing a carboxylic acid derivative of formula (I) (wherein all symbols are as defined in the specification), a non-toxic acid thereof or...
|
|
|
6960681 |
Guanidinomethyl cyclohexane carboxylic acid ester derivatives
The invention relates to novel and valuable intermediate compounds of the general formula (VIII) which can be used for the preparation of novel compounds comprising an antibacterial action,...
|
|
|
6909012 |
Diflunisal esters and related compounds
O-medium alkyl esters of diflunisal and related compounds are disclosed having anti-platelet activity, hydroxy radical scavenging properties, enhanced hepatic clearance and low ulcerogenic...
|
|
|
6869967 |
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these...
|
|
|
6762315 |
Method for producing (1,1′,4, 11″)-terphenyl compounds
The invention relates to a method for producing [1,1′:4′,1″]-terphenyl compounds of the formula which comprises reacting a metal aryl of the formula with a boric ester at −80 to 40° C. in the pres...
|
|
|
6653499 |
Photoactive propane derivatives and orientation layers
Compounds of formula (I) may be used as alignment layers in liquid crystal devices wherein X1-5 are idependently selected from H, F, CN, phenylene, C1-10 alkyl, whereby when X1=X2, then X1,2=H and...
|
|
|
6627656 |
Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
This invention encompasses a method for the treatment or prevention of prostaglandin mediated diseases comprising administering to a mammalian patient a compound of formula I: in an amount that is...
|
|
|
6518306 |
1,4-substitued 4,4-diaryl cyclohexanes
This invention relates to compounds of Formula (I) where Z is an amine, alcohol or derivative thereof, and the ketone analog thereof.
|
|
|
6452022 |
Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
This invention relates to a method of preparing a compound type where at least one of R′ or R″ is a carboxyl group (I) by treating a compound of formula (II) with a Group I(a) or Group II(a) met...
|
|
|
6376546 |
Biphenyl-5-alkanoic acid derivatives and use thereof
Compounds represented by general formula I or salts thereof, wherein n is an integer of 2 or 3; R represents a straight-chain or branched saturated alkyl group having 4 or 4 carbon atoms, a...
|
|
|
6369261 |
Compounds having activity as inhibitors of cytochrome P450RAI
Compounds having Formula 2 wherein the symbols have the meaning defined in the specification are inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme, and are used for treating...
|
|
|
6337408 |
Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
This invention relates to a method of preparing a compound of the following type by treating a compound of formula (II) with lithium bromide, magnesium bromide and the like.
|
|
|
6326397 |
Retinoid antagonists and use thereof
The present invention relates to novel retinoid antagonists of the formula I ##STR1##wherein the dotted bond can be either hydrogenated or form a double bond; and, when the dotted bond forms a...
|
|
|
6307089 |
Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
Biphenyl butyric acid compounds and derivatives are described as well as acid methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix...
|
|
|
6172239 |
Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors, their preparation and pharamaceutical compositions containing them
The invention relates to compounds of the formula ##STR1##The compounds have agreat affinity for the neurotensin receptors.
|
|
|
6147111 |
Phenyl derivatives useful as endothelin receptor antagonists
Novel phenyl derivatives which are useful as endothelin receptor antagonists.
|
|
|
6133469 |
Anti-ferroelectric liquid crystal compound
A novel anti-ferroelectric liquid crystal compounds of the formula (1), ##STR1## wherein R is a linear alkyl group having 6 to 12 carbon atoms, X is a hydrogen atom or a fluorine atom, m is an...
|
|
|
6110955 |
Metabolically stabilized oxyalkylene esters and uses thereof
This invention relates to compositions for and methods of treating, preventing or ameliorating cancer and other proliferative diseases as well as methods of inducing wound healing, treating...
|
|
|
6043232 |
Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
A compound comprising a non-steroidal antiinflammatory agent to which is directly or indirectly linked an NO group, a compound comprising an enolic anilide non-steroidal antiinflammatory agent to...
|
|
|
6013827 |
Compounds
This invention relates to componds of formula I ##STR1## which are useful as PDE IV inhibitors and for treating diseases related thereto.
|
|
|
5994379 |
Bisaryl COX-2 inhibiting compounds, compositions and methods of use
The present invention relates to inhibitors of COX-2, compositions which contain such compounds and methods of use. The compounds are represented by formula I: ##STR1## and include pharmaceutically...
|
|
|
5973190 |
Process and intermediate compounds for the preparation of pesticidal fluoroolefin compounds
The present invention provides a process for the preparation of pesticidal fluoroolefin compounds having the structural formula I ##STR1## The present invention also provides intermediate compounds...
|
|
|
5968908 |
Restricted 9-cis retinoids
The invention is novel analogs of 9-cis-retinoic acid which are useful for the treatment and prevention of coronary artery disease and to protect against premature atherosclerosis by increasing HDL...
|
|
|
5892098 |
3,3-(disubstituted)cyclohexan-1-one monomers and related compounds
This invention relates to derivatives of 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds which are useful for treating allergic and inflammatory diseases.
|
|
|
5767151 |
3,3-(disubstituted) cyclohexan-1-ylidine acetate dimers and related compounds
The present invention relates to novel 3,3-(disubstituted)-cyclohexan-1-ylidene acetate dimers of Formula (I): ##STR1## and related compounds, pharmaceutical compositions containing these...
|
|
|
5728864 |
Liquid crystal compound having ferrielectric phase and liquid crystal composition
A liquid crystal compound of the formula (1) ##STR1## wherein R is a linear alkyl group having 6 to 12 carbon atoms, both X and Y are hydrogen atoms or one of X and Y is a fluorine atom and the...
|
|
|
5719184 |
3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds
The present invention relates to novel 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds, pharmaceutical compositions containing these compounds, and their use in treating...
|
|
|
5710277 |
Process for R (+) 1,2,3,6-tetrahydro-4-phenyl-1- (3-phenyl-3-cyclohexen-1-yl)methyl!pyridi ne, a central nervous system agent
An improved process for the preparation of R(+)1,2,3,6-tetrahydro-4-phenyl-1- (3-phenyl-3-cyclohexen-1-yl)methyl!pyri dine by a novel synthesis is described where...
|
|
|
5691376 |
Substituted biphenyl derivatives
A compound of the following structure: ##STR1## wherein R8 =H: R1 =alkyl, cycloalkyl, arylalkyl, aryl; R2 =cycloalkyl, aryl, C3 -C10 alkyl; X,Y=O, S(O)n, NH; Z=CO2 R3, C(O)CO2 R3, CH(OH)CO2 R3,...
|
|
|
5663413 |
Biphenyl iodinated derivatives and their diagnostic use
The invention relates to novel contrast media particularly useful for X-ray diagnostic investigations of human and animal body.
|
|
|
5536845 |
Acrylates containing an alcohol, aldehyde and/or ether functional group, process for their manufacture and their application to the production of new polymers and copolymers
Process for the preparation of the acrylates chosen from those of formula ##STR1## those of formula ##STR2## and those of the formula ##STR3## useful in the production of new polymers and copolymers.
|
|
|
5494605 |
P-terphenyl derivatives and liquid crystalline compositions
The p-terphenyl derivatives of the formula shown below are useful in preparing practical ferroelectric liquid crystalline compositions. The derivatives exhibit excellent chemical stability and...
|
|
|
5475132 |
Antifungal agents based on amides containing a phenyl group
R3, R4 and R5, each represents a hydrogen or halogen atom (at least one of R3, R4 and R5 being other than hydrogen or halogen); optionally substituted amino; optionally halogenated or hydroxylated...
|